The following links are provided by IPC for the benefit of its users and members. IPC does not attest to the accuracy of or assume any responsibility for the content or information provided by linked sites, nor does it endorse or recommend any specific content or information contained therein. Please be aware that when you exit the IPC website you are subject to the policies and procedures of the new site.
North American
In the latest Psoriasis Review IPC's bi-annual review of the latest news in the field of psoriasis. read the latest issue
Psoriasis News Lilly to Present 5-Year Sustained Efficacy and Safety Results for Taltz® (ixekizumab) in Patients with Plaque Psoriasis at the World Congress of Dermatology6/11/2019 9:58:00 AM Review of international psoriasis guidelines for the treatment of psoriasis: recommendations for topical corticosteroid treatments6/5/2019 12:03:00 PMCorticosteroid therapy is regarded as first-line therapy for treating mild psoriasis and recalcitrant lesions. Members of the IPC Topical Therapies Working Group reviewed available international topical corticosteroids guidelines in order to understand current information and to identify areas that would benefit from greater practical guidance for dermatologists. FDA Approves ETICOVO™ (etanercept-ykro), Samsung Bioepis' Second Anti-TNF Medicine in the United States4/29/2019 7:28:00 AM AbbVie Announces Approval of SKYRIZI™ for the Treatment of Psoriasis in US, Canada, Europe and Japan4/28/2019 8:26:00 PM More News